Results 81 to 90 of about 16,509 (247)

Rapid detection of fibrinogen and fibrin degradation products by latex piezoelectric immunoassay

open access: yes, 2020
It was developed a conventional immunosensor for fibrinogen and fibrin degradation products (FDP) to combine a quartz crystal microbalance (QCM) with the agglutination reaction of immunized latex beads.
Park, J-W   +6 more
core  

Effect of fibrinogen degradation products on various stages of the fibrinolytic process

open access: yes, 2015
Over-activation of the fibrinolytic system may result in proteolytic destruction of fibrinogen. However, the effect of the degradation products formed during fibrinogenolysis on fibrinolytic process and plasminogen/plasmin properties remains unclear.
Rybachuk, V.N.   +4 more
core   +1 more source

How periodontal disease may contribute to cardiovascular disease [PDF]

open access: yes, 2000
No abstract ...
Lowe, G.D.O.   +3 more
core   +1 more source

A retrospective study on predicting postoperative functional recovery in patients with rotator cuff injuries based on MRI quantitative parameters

open access: yesJournal of Radiation Research and Applied Sciences
Background: Rotator cuff injuries are common shoulder disorders, yet predicting postoperative functional recovery remains challenging. This study aimed to investigate the predictive value of preoperative MRI quantitative parameters and serum biomarkers ...
Ming Xu   +6 more
doaj   +1 more source

Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration

open access: yesBMEMat, EarlyView.
The blood clot, owing to its dynamic composition and unique microenvironment, holds significant yet underappreciated potential for tissue engineering. This review systematically summarizes the pathophysiology of clot formation, the key regulatory factors shaping its microenvironment, and its applications in both pre‐clinical and clinical settings ...
Gao‐peng Dang   +13 more
wiley   +1 more source

Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.

open access: yes, 1986
In a group of 39 patients who received fibrinolytic therapy for acute myocardial infarction, serum crosslinked fibrin degradation products (XLDP) were quantitated by an enzyme-linked immunosorbent assay (ELISA) using an antibody reactive with a site near
C W Francis, V J Marder, D G Connaghan
core   +1 more source

An Evaluation of Hemostatic Dysregulation in Canine Multicentric Lymphoma

open access: yesAnimals
Multiple hemostatic abnormalities are associated with paraneoplastic syndrome and some malignant tumors. Lymphoma is the most common hematopoietic neoplasm in dogs, sometimes associated with hemostatic changes.
Maria Ludovica Messina   +4 more
doaj   +1 more source

Implantable electrochemical sensors for continuous blood monitoring

open access: yesFlexMat, EarlyView.
Implantable electrochemical sensors enable direct, in situ, and continuous blood monitoring, shifting diagnosis from population‐based averages to dynamic, individualized analysis. This review systematically examines the influence of the unique blood properties on sensor design.
Kuangyi Zou   +3 more
wiley   +1 more source

Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.

open access: yes, 1990
Concentrations of cross-linked fibrin degradation products (XL-FDPs) in plasma, measured by enzyme-linked immunosorbent assays (ELISAs) based on monoclonal antibodies (MAbs) raised against fragment D-dimer of cross-linked fibrin, increase when patients ...
E G Bovill   +4 more
core   +1 more source

COVID-19 Associated Coagulopathy and Implications for its Treatment

open access: yesActa Medica Bulgarica, 2020
The SARS-CoV-2 coronavirus (COVID-19) pandemic is due to lack of prior immunity and there is no certain management, regarding the complications of this viral illness. The target organ for COVID-19 infection are the lungs.
Cherneva Zh., Cherneva R.
doaj   +1 more source

Home - About - Disclaimer - Privacy